AltheaDx Obtains $30,000,000 Series C Funding Round

  • Feed Type
  • Date
    12/14/2015
  • Company Name
    AltheaDx
  • Mailing Address
    3550 Dunhill Street San Diego, CA 92121 USA
  • Company Description
    Our proprietary gene expression profiles include assays for differential diagnosis of pediatric cancers and for improved diagnosis and management of prostate cancer.
  • Website
    http://www.altheadx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    This investment will enable the company to invest in prospective outcome trials for its IDgenetix testing portfolio and expand its commercial capabilities. The Series C financing will also provide capital for product enhancements, international opportunities as well as other investments in long-term growth.
  • M&A Terms
  • Venture Investor
    WuXi PharmaTech
  • Venture Investor
    Ally Bridge Group
  • Venture Investor
    Undisclosed